Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree with you - they've rightfully concluded that all the best efforts of enthusiastic longs posting to message boards isn't going to get the job done of moving this to $2 for a consistent period of time so they can uplist, and they realize that they need professional assistance to move this process along further. It indicates to me a management team that understands what it needs in an important facet of their business, and that, to me, may be the best thing about this release.
I don't know, and I don't think anyone knows, the correct valuation of the company at this point, because their future revenue streams are not and cannot yet be well-defined. What I do believe is that it's in excess of the current share price, and I'm quite happy to wait to see how the future high-growth-potential revenue streams develop and contribute to its valuation.
I missed the opening this morning, and by the time I got to the computer, it had moved up to $13.44, which I was very happy to pay in doubling my position. This is an exciting company to watch as it develops. What I liked most about the call was the sense of quiet excitement in the CEO's voice, and his obvious complete command of all facets of his business.
If it goes to $4, I could buy a house in Vegas!
It's hard for me to believe that people are stupid enough to think that this company is worth 52% of what it was yesterday just because the FDA apparently has some issues with the application. I bought in today at $23.79 and am very happy to have gotten such a tremendous discount on the company's valuation.
If this closes above $2 in the next leg, I'll call you whatever you want to be called!
Did anyone hear the conference call this afternoon? Does anyone realize that they have two massive JV partners who both want and need them to succeed? Does anyone realize how disarmingly competent this management team (CEO/CFO) is? Does anyone know that they have such a superior infrastructure in this country to all other competitors that they will be the provider of choice when large companies want to convert their fleets to RNG? I did and do now, and I will be doubling my position tomorrow morning.
I very sadly said goodbye to my beloved Mustang this morning at a slight profit in order to buy another stock whose price had just become too attractive and has disruptive prospects in its industry (NVTA). This is still a very promising company and I may yet return when I have more investment capital, but for now I had to leave. I think any buyer will be pleased in the long run if they buy Mustang at this price.
I never took the position I referred to in my prior post because I used the money for another stock, and now I'm glad I didn't, because this has fallen by a third from its recent public offering price. I got in at just over $34.00 this morning, and I look at it as a tremendous gift from the market. This is similar at this point to where Facebook or Netflix was when they started, in that they see a future of which very few others can conceive. I'm not technically presumptuous enough to say that I understand that future, but I can see that they do, and that should be enough to make me a lot of money by owning part of this company.
The company doesn't have any money with which to buy back stock, as they are in an expansionary phase, and every dollar they have needs to be used to develop their nascent businesses that will create high-margin revenue streams and related earnings that will result in a higher share price over time.
I take it you haven't read this morning's announcement.
Keep those high-margin revenue streams coming! You're doing a great job.
The best thing about having invested here is that we don't need luck, only time.
There's nothing in the balance sheet that needs to be addressed. What people see in the current financial statements is a high-volume, low-margin operation that is running at basically breakeven. What the company is becoming is a multifaceted conglomerate that will have multiple revenue streams that will contribute increasing amounts of revenue at higher margins and lead to significant profitability. It's trading at what it currently appears to be on the face of its financial statements. We've bought in because we can see into its future.
I find it easier to tolerate when I know that we have a company whose share price is supported by a viable and fast-growing multifaceted business instead of by hype and virtually nothing else like most of the companies that trade in the Pink Sheet swamp.
No one would like to see that be the case more than I!
We'll see it again - it's just a matter of when, not if.
If I were to tell you that I understand the moves this stock's price makes, I'd be lying. All I know is that I'm holding through whatever happens because I know where it's eventually going, and that's up.
The 10-K should be filed on March 30. If they can get it done on time without needing an extension, I would consider that to be a big plus. The CPA firm that audits the statements is of very high quality, so hopefully they can work with him to coordinate the audit to get it done on time.
That sounds exciting - we're looking forward to hearing about it!
Just an expansion, clarification, and follow-on to the exchange I posted earlier today from the Ambassadors board regarding the potential $26 million in revenue announced this morning:
Ambassador: This is potential revenue, not booked revenue, correct?
iQSTEL: Estimated based on both booked and projected.
Ambassador: Is this on top of your projected 60ml 2021?
iQSTEL: Yes.
I thought this was an interesting exchange on the Ambassadors board regarding the $26 million in potential revenue announced this morning. I thought from the press release that all of the revenue was entirely forecasted, but this indicates that they have already booked some of the revenue. It's very positive to me that the new product has already resulted in actual bookings.
Ambassador: This is potential revenue, not booked revenue, correct?
iQSTEL: Estimated based on both booked and projected.
The guess here is that because this release isn't yet public, but was released early only to the Ambassadors website, some prying eyes got hold of it and tried to drive down the price before its public release, as this news seems substantial enough to drive the price up.
That would be nice. I'm encouraged that it's showing some strength today in the face of low volume. Just like any other pink sheet stock, low volume usually equals a declining share price without exciting news or demonstrable indications of increasing sales and hopefully accompanying profitability to recharge the interest level in buying.
Does anyone really care?
I like it. It sounds like a decision made by a management team that has control of its operations and a strong understanding of how best to grow its business. This is an impressive management team for any company, let alone one that trades on the pink sheets.
Good point - I don't plan to sell at $10, but as always, if and when the share price exceeds what I deem to be the appropriate enterprise valuation based on the projected future discounted cash flows of the enterprise, I will sell it, as I would with any other stock. I try never to invest with my heart, only with my head. And yes, I would sell it slowly to avoid pressuring the share price.
Wow - that would make the company's market cap $2.4 billion. This company has great prospects, but it's got a ways to go before it earns out that valuation!
$10 might be a good point at which to sell half - and it might not!
I like this at the current price level. This could be as good or better than GTHX. I'm in on Monday morning.
I sold out a while ago to buy something else, but I'm back in on Monday morning. A lot of knowledgeable investors just bought in at $7.00, and I'm happy to rejoin them at about that level.
I sold out a while ago to buy something else, but I'm back in on Monday morning. The current price is ridiculous.
I think they're right - any news would just die in this lousy market environment. Since the name of the game is so obviously to get the share price to $2.00 for a sustained period of time, they should save the news until releasing it can achieve an optimal result.
To be honest, in this horrific market environment, I'm surprised the price has held up as well as it has.
They are MBIO, SIOX, and GTHX. GTHX will be the most successful of the three, as they have a recently-approved drug that will change the face of the use of chemotherapy. It is still amazingly cheap relative to its value, and is an easy three-bagger within at most two years, and probably before that.
You do realize that the press release you have posted is dated December 7, 2018, and has no basis in current reality.
Where did I say I was selling? Right now I wish I had sold it all yesterday at $1.86!
I'd like to see it! I'd be very happy with that result by the end of this year.
I would guess no - I think iQSTEL's developing technologies would have to prove to be able to generate significant revenue and income streams and be better established before a larger company would want to take it over.
It's nearly a six-bagger for me, but I'm not selling a single share. It's an extreme rarity with a pink sheet stock that I wouldn't sell at this point, but this is an extremely rare company living in pink sheet land.